|
(4Z,7Z,10Z,14E,16Z,19Z)-13-oxodocosahexaenoic acid |
|
CHEBI:140204 |
|
(4Z,7Z,10Z,14E,16Z,19Z)-13-oxodocosahexaenoic acid |
|
An oxodocosahexaenoic acid that is (4Z,7Z,10Z,14E,16Z,19Z)-docosahexaenoic acid in which the oxo group is located at position 13. An intermediate of specialised proresolving mediators. |
|
This entity has been manually annotated by the ChEBI Team.
|
|
Bijay
|
|
|
|
Molfile
XML
SDF
|
|
|
|
InChI=1S/C22H30O3/c1-2-3-4-5-9-12-15-18-21(23)19-16-13-10-7-6-8-11-14-17-20-22(24)25/h3-4,6-7,9,11-16,18H,2,5,8,10,17,19-20H2,1H3,(H,24,25)/b4-3-,7-6-,12-9-,14-11-,16-13-,18-15+ |
JGZAOFOLFDPNTJ-SKSHMZPZSA-N |
C(C(O)=O)C/C=C\C/C=C\C/C=C\CC(/C=C/C=C\C/C=C\CC)=O |
|
Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
|
|
human xenobiotic metabolite
Any human metabolite produced by metabolism of a xenobiotic compound in humans.
|
|
View more via ChEBI Ontology
Outgoing
|
(4Z,7Z,10Z,14E,16Z,19Z)-13-oxodocosahexaenoic acid
(CHEBI:140204)
has functional parent
all-cis-docosa-4,7,10,13,16,19-hexaenoic acid
(CHEBI:28125)
(4Z,7Z,10Z,14E,16Z,19Z)-13-oxodocosahexaenoic acid
(CHEBI:140204)
has role
human xenobiotic metabolite
(CHEBI:76967)
(4Z,7Z,10Z,14E,16Z,19Z)-13-oxodocosahexaenoic acid
(CHEBI:140204)
is a
enone
(CHEBI:51689)
(4Z,7Z,10Z,14E,16Z,19Z)-13-oxodocosahexaenoic acid
(CHEBI:140204)
is a
oxodocosahexaenoic acid
(CHEBI:134542)
(4Z,7Z,10Z,14E,16Z,19Z)-13-oxodocosahexaenoic acid
(CHEBI:140204)
is conjugate acid of
(4Z,7Z,10Z,14E,16Z,19Z)-13-oxodocosahexaenoate
(CHEBI:140236)
|
|
Incoming
|
(4Z,7Z,10Z,14E,16Z,19Z)-13-oxodocosahexaenoate
(CHEBI:140236)
is conjugate base of
(4Z,7Z,10Z,14E,16Z,19Z)-13-oxodocosahexaenoic acid
(CHEBI:140204)
|
(4Z,7Z,10Z,14E,16Z,19Z)-13-oxodocosa-4,7,10,14,16,19-hexaenoic acid
|
(4Z,7Z,10Z,14E,16Z,19Z)-13-ketodocosahexaenoic acid
|
ChEBI
|
13-oxo-(4Z,7Z,10Z,14E,16Z,19Z)-docosahexaenoic acid
|
ChEBI
|
13-oxo-DHA
|
SUBMITTER
|
13-oxodocosahexaenoic acid
|
ChEBI
|
26339618
|
PubMed citation
|
Europe PMC
|
|